Publications for Dr. Steven Gray

Featured Publications Legend

Featured Publications

Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery.

Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, Bailey MES, Cobb SR, Gray SJ Mol Ther Methods Clin Dev 2017 Jun 5 106-115

Functional Analysis of the Ser149/Thr149 Variants of Human Aspartylglucosaminidase and Optimization of the Coding Sequence for Protein Production.

Banning A, König JF, Gray SJ, Tikkanen R Int J Mol Sci 2017 Mar 18 4

N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.

Francis JS, Wojtas I, Markov V, Gray SJ, McCown TJ, Samulski RJ, Bilaniuk LT, Wang DJ, De Vivo DC, Janson CG, Leone P Neurobiol. Dis. 2016 Dec 96 323-334

Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria.

Banning A, Gülec C, Rouvinen J, Gray SJ, Tikkanen R Sci Rep 2016 Nov 6 37583

Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism.

Powell SK, Khan N, Parker CL, Samulski RJ, Matsushima G, Gray SJ, McCown TJ Gene Ther. 2016 Nov 23 11 807-814

Immunological considerations for treating globoid cell leukodystrophy.

Karumuthil-Melethil S, Gray SJ J. Neurosci. Res. 2016 11 94 11 1349-58

Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.

Karumuthil-Melethil S, Marshall MS, Heindel C, Jakubauskas B, Bongarzone ER, Gray SJ J. Neurosci. Res. 2016 11 94 11 1138-51

Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease.

Armao D, Bailey RM, Bouldin TW, Kim Y, Gray SJ Clin. Auton. Res. 2016 Aug 26 4 307-13

Systemic Gene Transfer of a Hexosaminidase Variant Using an scAAV9.47 Vector Corrects GM2 Gangliosidosis in Sandhoff Mice.

Osmon KJ, Woodley E, Thompson P, Ong K, Karumuthil-Melethil S, Keimel JG, Mark BL, Mahuran D, Gray SJ, Walia JS Hum. Gene Ther. 2016 Jul 27 7 497-508

Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease.

Karumuthil-Melethil S, Nagabhushan Kalburgi S, Thompson P, Tropak M, Kaytor MD, Keimel JG, Mark BL, Mahuran D, Walia JS, Gray SJ Hum. Gene Ther. 2016 Jul 27 7 509-21

Results 11-20 of 24